The protein p19, also known as the p19 subunit of the RNA polymerase III transcription factor TFIIIB, is a critical component involved in the transcription of various small non-coding RNAs, including transfer RNAs (tRNAs), 5S ribosomal RNA (rRNA), and other small nuclear RNAs (snRNAs). As part of the TFIIIB complex, p19 plays a central role in initiating the transcription of these essential RNA molecules, which are integral for protein synthesis and other fundamental cellular processes. Specifically, p19 functions by binding to promoter regions of target genes and recruiting RNA polymerase III, facilitating the assembly of the transcription initiation complex and promoting the accurate and efficient transcription of target genes into their respective RNA products.
The activation of p19 is a tightly regulated process that involves multiple steps and factors. One key mechanism of p19 activation is its interaction with other components of the RNA polymerase III transcription machinery, including TFIIIB subunits such as BRF1 and BRF2. These interactions stabilize the formation of the TFIIIB complex and enhance its affinity for target gene promoters, thereby facilitating the recruitment of RNA polymerase III and promoting transcription initiation. Additionally, post-translational modifications, such as phosphorylation and acetylation, can modulate the activity and stability of p19, further regulating its function in RNA polymerase III-mediated transcription. Furthermore, the expression levels of p19 and its regulatory factors can be influenced by various cellular signals and environmental cues, providing additional layers of control over the transcriptional activity of RNA polymerase III and the synthesis of essential RNA molecules. Overall, the precise regulation of p19 activation is crucial for maintaining proper cellular function and gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor, may influence gene expression including that of CDKN2D. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another histone deacetylase inhibitor, potentially affecting CDKN2D expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, could affect CDKN2D expression by altering DNA methylation. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
MDM2 inhibitors can stabilize p53, potentially enhancing the expression of p53-responsive genes like CDKN2D. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could indirectly influence CDKN2D through cellular growth and metabolic pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially affecting signaling pathways involved in CDKN2D regulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which may indirectly affect CDKN2D through the MAPK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, potentially influencing pathways related to CDKN2D activity. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
A flavonoid with antioxidant properties, may affect various signaling pathways influencing CDKN2D. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known to modulate sirtuins and NF-κB pathway, possibly affecting CDKN2D indirectly. | ||||||